PH21886A - Spiro imidazolones for treatments of diabetes complications - Google Patents
Spiro imidazolones for treatments of diabetes complicationsInfo
- Publication number
- PH21886A PH21886A PH32539A PH32539A PH21886A PH 21886 A PH21886 A PH 21886A PH 32539 A PH32539 A PH 32539A PH 32539 A PH32539 A PH 32539A PH 21886 A PH21886 A PH 21886A
- Authority
- PH
- Philippines
- Prior art keywords
- spiro
- pct
- imidazolones
- treatments
- diabetes complications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1984/001155 WO1986000807A1 (en) | 1984-07-20 | 1984-07-20 | Spiro-imidazolones for treatment of diabetes complications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH21886A true PH21886A (en) | 1988-03-25 |
Family
ID=22182207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH32539A PH21886A (en) | 1984-07-20 | 1985-07-18 | Spiro imidazolones for treatments of diabetes complications |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4680306A (fi) |
| EP (1) | EP0171213B1 (fi) |
| KR (1) | KR870000626B1 (fi) |
| AT (1) | ATE37372T1 (fi) |
| AU (1) | AU553719B2 (fi) |
| CA (1) | CA1246085A (fi) |
| DE (1) | DE3565106D1 (fi) |
| DK (1) | DK329485A (fi) |
| EG (1) | EG17281A (fi) |
| ES (1) | ES8604594A1 (fi) |
| FI (1) | FI80037C (fi) |
| GR (1) | GR851763B (fi) |
| HU (1) | HU198212B (fi) |
| IL (1) | IL75801A (fi) |
| PH (1) | PH21886A (fi) |
| PL (1) | PL145598B1 (fi) |
| PT (1) | PT80829B (fi) |
| WO (1) | WO1986000807A1 (fi) |
| ZA (1) | ZA855460B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3501B1 (ar) * | 2014-12-22 | 2020-07-05 | Servier Lab | مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985888A (en) * | 1969-07-24 | 1976-10-12 | Richardson-Merrell Inc. | Methods of inducing sedation using certain spiroalkanone-imides |
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
| US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| IE52879B1 (en) * | 1981-05-12 | 1988-03-30 | Ici Plc | Pharmaceutical spiro-hydantoin derivatives |
| ATE11781T1 (de) * | 1981-05-13 | 1985-02-15 | Imperial Chemical Industries Plc | Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten. |
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
-
1984
- 1984-07-20 US US06/842,109 patent/US4680306A/en not_active Expired - Lifetime
- 1984-07-20 HU HU843235A patent/HU198212B/hu not_active IP Right Cessation
- 1984-07-20 WO PCT/US1984/001155 patent/WO1986000807A1/en active IP Right Grant
-
1985
- 1985-06-27 CA CA000485492A patent/CA1246085A/en not_active Expired
- 1985-07-15 IL IL75801A patent/IL75801A/xx unknown
- 1985-07-16 GR GR851763A patent/GR851763B/el unknown
- 1985-07-18 EG EG428/85A patent/EG17281A/xx active
- 1985-07-18 DE DE8585305115T patent/DE3565106D1/de not_active Expired
- 1985-07-18 PH PH32539A patent/PH21886A/en unknown
- 1985-07-18 KR KR1019850005114A patent/KR870000626B1/ko not_active IP Right Cessation
- 1985-07-18 AT AT85305115T patent/ATE37372T1/de active
- 1985-07-18 ES ES545353A patent/ES8604594A1/es not_active Expired
- 1985-07-18 PT PT80829A patent/PT80829B/pt not_active IP Right Cessation
- 1985-07-18 EP EP85305115A patent/EP0171213B1/en not_active Expired
- 1985-07-18 PL PL1985254593A patent/PL145598B1/pl unknown
- 1985-07-19 ZA ZA855460A patent/ZA855460B/xx unknown
- 1985-07-19 DK DK329485A patent/DK329485A/da not_active Application Discontinuation
- 1985-07-19 AU AU45189/85A patent/AU553719B2/en not_active Ceased
-
1986
- 1986-03-18 FI FI861125A patent/FI80037C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE37372T1 (de) | 1988-10-15 |
| GR851763B (fi) | 1985-11-26 |
| ES545353A0 (es) | 1986-02-01 |
| FI80037C (fi) | 1990-04-10 |
| EP0171213B1 (en) | 1988-09-21 |
| ES8604594A1 (es) | 1986-02-01 |
| FI861125A (fi) | 1986-03-18 |
| KR860001114A (ko) | 1986-02-22 |
| DE3565106D1 (en) | 1988-10-27 |
| PT80829B (pt) | 1987-11-30 |
| US4680306A (en) | 1987-07-14 |
| HU198212B (en) | 1989-08-28 |
| HUT39087A (en) | 1986-08-28 |
| AU4518985A (en) | 1986-01-23 |
| KR870000626B1 (ko) | 1987-03-26 |
| WO1986000807A1 (en) | 1986-02-13 |
| EG17281A (en) | 1989-06-30 |
| FI80037B (fi) | 1989-12-29 |
| IL75801A (en) | 1988-09-30 |
| AU553719B2 (en) | 1986-07-24 |
| FI861125A0 (fi) | 1986-03-18 |
| DK329485D0 (da) | 1985-07-19 |
| DK329485A (da) | 1986-01-21 |
| EP0171213A1 (en) | 1986-02-12 |
| PL254593A1 (en) | 1986-06-17 |
| PL145598B1 (en) | 1988-10-31 |
| PT80829A (en) | 1985-08-01 |
| ZA855460B (en) | 1987-02-25 |
| CA1246085A (en) | 1988-12-06 |
| IL75801A0 (en) | 1985-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1808488A (en) | Compounds for the treatment of alzheimer's disease | |
| ES483511A1 (es) | Un procedimiento para la preparaion de nuevas espiro-oxazo- lidinohoinas. | |
| HRP920667A2 (en) | Application of fultripine active substance for preventing muscle deformation | |
| GR3034508T3 (en) | Use of insulin sensitizing agents to treat hypertension. | |
| PL320167A1 (en) | 2,2-dichloroalkanocarboxylic acids, method of obtaining them and therapeutic agents containing such compounds and their application in treating insulin immunity | |
| HUT71550A (en) | Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis | |
| GR861803B (en) | Novel carbonic acid derivatives method for their preparation their use and medicine containing them | |
| GB2188547B (en) | Tamoxifen composition for the treatment of psoriasis. | |
| GR852979B (fi) | ||
| ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
| RO92632A (ro) | Compozitie farmaceutica sinergetica pentru tratamentul inflamatiilor pancreasului | |
| PH21886A (en) | Spiro imidazolones for treatments of diabetes complications | |
| IE832854L (en) | Spiro-3-hetero-azolones for treatment of diabetic¹complications. | |
| DE3467166D1 (en) | Spiro-succinimides for treatment of diabetes complications | |
| ZA871032B (en) | Pharmaceutical compositions for the therapy of cerebropatheis on functional and organic base | |
| NO972450L (no) | Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav | |
| IL98200A0 (en) | Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide | |
| ES8609326A1 (es) | Un procedimiento para la preparacion de nuevas 1-(aril sustituido)dihidro 1h pirrolizin-3,5-(h,6h)-dionas | |
| SI1304107T1 (en) | Use of oxazolidinines derivatives for treating psoriasis |